Valeant Stock Dips Back Below 200-Day Moving Average

Short-term options traders are targeting VRX

Oct 13, 2017 at 2:32 PM
facebook twitter linkedin

Shares of Valeant Pharmaceuticals Intl Inc (NYSE:VRX) are sliding for a second straight day, with traders possibly responding to a phase 3 trial update for Siliq -- a product of subsidiary Ortho Dermotologics. VRX stock was last seen 3.9% lower at $13.29, putting the equity on pace to close below its 200-day moving average for the first time in over a month. However, it bottomed out just above the $13 level earlier, a level that contained its late-August, early September pullback.

valeant pharmaceuticals

In the meantime, options traders are jumping on near-term puts. Put volume today is running at two times the expected pace, which is nothing new. Valeant has a Schaeffer's put/call open interest ratio (SOIR) of 1.86, ranking only 2 percentage points from a 12-month low. In other words, options traders targeting contracts that expire within three months have been unusually put-skewed.

It's hard to blame anyone for wanting to use short-term options to speculate on VRX stock. That's because the security has a Schaeffer's Volatility Index (SVI) of 41%, ranking just 2 percentage points from a 12-month low -- pointing toward lower-than-usual volatility expectations. Moreover, a Schaeffer's Volatility Scorecard (SVS) of 94 points toward a tendency to blow past options traders' expectations.


Minimize Risk While Maximizing Profits

There is no options strategy like this one, which consistently minimizes risk while maintaining maximum profits. Perfect for traders looking for ways to control risk, reduce losses, and increase the likelihood of success when trading calls and puts. The Schaeffer’s team has over 41 years of options trading success targeting +100% gains on every trade. Rest assured your losses are effectively limited to your initial cost at the time of making your move! Don't waste another second... join us right now before the next trade is released! 



Special Offers from Schaeffer's Trading Partners